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osting by EAbstract There is strong evidence that supports the role of tumour necrosis factors (TNF-alpha/
beta) as common genetic factors, located on 6p21.1–6p21.3 loci, in the pathogenesis of asthma dis-
ease. In this study, we extended our research work on TNFA to include the genotyping of Saudi
asthmatic children as regards to TNFB gene (namely as lymphotoxin-a, LTA). We examined 60
asthmatic Saudi children compared to 56 healthy non-asthmatics using the PCR-RFLP analyses
to identify the polymorphism +252A>G in intron 1 in lymphotoxin-a gene. We identiﬁed 55%
of the allele A of the LTA*NcoI polymorphism in subjects with asthma disease, and 45% of the
allele G. In this study, the frequency of the LTA*NcoI-A/A genotype was 40% preferably to the
LTA*NcoI-G/A and LTA*NcoI-G/G genotypes. In addition, the severe persistent asthmatic cases
were associated with the LTA*NcoI-AA genotype at a frequency of 80%, while the genotype
LTA*NcoI-GG are associated with the mildest form of the disease. Consequently, one could predict
the severity of asthma and hence the polymorphism of the LTA*NcoI. Herein, we stated that more
than 93% of Saudi children under investigation lived in the randomized areas of western regions of
Saudi Arabia. In conclusion, genotype frequencies for the LTA+252 polymorphisms were signiﬁ-
cantly different from the controls. These ﬁndings may have implications for future early interven-
tion studies by helping to identify infants at increased risk for wheezing and childhood asthma.
ª 2010 King Saud University. All rights reserved., ejiffri@hotmail.com (E.H.
ity. All rights reserved. Peer-
d University.
lsevier1. Introduction
Asthma (MIM #600807) is a common respiratory disease char-
acterized by variable airﬂow obstruction, inﬂammation of the
airways, and bronchial hyper responsiveness (BHR). It affects
nearly 14 million people worldwide and has been steadily
increasing in frequency for the past 50 years (Weiss et al.,
2009). It is one of the most common chronic diseases in Saudi
Arabia, affecting more than 2 million Saudis (Al Frayh et al.,
2001). Its impact is manifested in patients, their families, and
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days, poor quality of life, frequent emergency department vis-
its, hospitalizations, and death cases (Stewart et al., 2003).
Therefore, international guidelines have been developed to
help the physicians to manage asthma in a better way and deal
with different presentations and situations using the best avail-
able evidence (Al-Mobeireek, 2003).
Although a large number of studies of asthma have been
conducted, the etiology of childhood asthma remains to be
ﬁrmly established. Asthma is a complex disorder involving
immunologic, genetic, environmental, and other factors.
Allergic sensitization appears to be the strongest identiﬁable
predisposing factor for asthma (Sears et al., 1991). Non-aller-
gic individuals, however, are also affected by asthma. The
inﬂammatory reaction of the airways in asthma, accompanied
by recruitment and activation of eosinophils and T-lympho-
cytes, is the cardinal feature of the disease (Montefort
et al., 1993).
The mode of inheritance of asthma is complex and not
yet fully understood (Weiss et al., 2009). It is likely that sev-
eral genes, each with moderate-to-major effects, act together
with environmental exposures to determine an individual’s
overall risk of development of asthma. The Collaborative
Study on the Genetics of Asthma (CSGA), a multicenter col-
laborative study supported by the National Heart, Lung and
Blood Institute of the NIH (NHLBI/NIH), identify impor-
tant loci that contribute to the development of asthma and
asthma-associated phenotypes. Chromosome 6p21 is one of
the best-characterized regions in the human genome and
the nucleotide sequence between D6S258 and D6S265 is
known (Mungall et al., 2003; Stewart et al., 2004). This re-
gion is gene rich, with 20 known or predicted genes and at
least 30 pseudogenes in the 1-Mb region from HLA-A to
OR2B3 (Nicolae et al., 2005). The polymorphism (308G/
A) in the promoter of tumour necrosis factor A (TNFA),
was identiﬁed and reported to be associated with asthma
(Moffatt and Cookson, 1997; Winchester et al., 2000; Biloli-
kar et al., 2005) and increased bronchial hyperresponsiveness
(Gorska et al., 2010). TNFA (MIM #191160) and TNFB
(MIM #153440), located 13-kb apart on chromosome 6p21,
shares a common receptor on tumour cells (Aggarwal
et al., 1985). The frequency of 308A allele in TNFA varies
signiﬁcantly between ethnic groups and it is rare in the East-
ern populations (Li Kam Wa et al., 1999; Noguchi et al.,
2002). Other more common polymorphisms in the promoter
of TNFA (1031T/C, 863C/A and 857C/T) have been
identiﬁed (Ozaki et al., 2003). Homozygosity for a +252A/
G change in intron 1 of the LTA gene was associated signif-
icantly with increased risk for myocardial infarction (Ozaki
et al., 2003). Functional studies have indicated that the sub-
stitution in intron 1 may affect transcription of LTA.
Although some studies have shown no signiﬁcant associa-
tion, the +252A/G intronic polymorphism in LTA gene
was reported to be associated with asthma (Albuquerque
et al., 1998; Castro et al., 2000).
Despite earlier clinical studies that were discussed on asth-
matic Saudi children, none have contained candidate genes
responsible for the causes of the disease (Kumar and Ghosh,
2009). In this study, we examined the genetic effects of LTA
gene polymorphism on the asthma in Saudi families identiﬁed
through children with asthma.2. Materials and methods
2.1. Patients and phenotypes
A respiratory questionnaire based on the standard MRC
respiratory questionnaire was administered as previously de-
scribed (Hill et al., 1995). A sample group of 60 probands
and 56 healthy subjects were recruited from bronchial asth-
matic children attending the Clinic of Chest at Pediatrics hos-
pitals of Western regions of KSA. All the subjects were tested
for clinical history, total serum IgE level, skin prick test
(SPT), and BHR. The asthmatic children were classiﬁed
according to the criteria of Global Initiative for Asthma
(GINA, 2004) into four groups; mild intermittent asthma
(12 cases), mild persistent asthma (20 cases), moderate persis-
tent asthma (36 cases) and severe persistent asthma (10 cases)
(Table 1). These categories were described based on the sever-
ity of disease and PEF or PEF/PEF variability. (a) Mild
intermittent BA: symptoms of bronchial asthma <1 time/
week at day, normal PEF between attacks and <2 times/
month at night (PEF or FEV1/PEF variability, P80%/
<20%). (b) Mild persistent: symptoms >1 time/week at
day, >2 times/month at night and attacks affect the activity
(P80%/20–30%). Moderate persistent: Symptoms of .asthma
occur daily during the day and >1 time/week during the
night and attacks affect activity (60–80%/>30%). Severe
persistent: Symptoms are continuous at day and frequent at
night with a limited physical activity (660%/>30%) (Global
Initiative for Asthma, GINA, 2004).2.2. LTA gene analysis
Genomic DNA was extracted from blood lymphocytes using
Spin column genomic DNA kit (Bio Basic Inc., Ontario,
Canada). In some cases, DNA was prepared in situ by gentle
scraping of the buccal mucosa for 30 s using a cytobrush
(Elhawary et al., 2004). The cells obtained were treated di-
rectly with diluted NaOH solution, heated, and neutralized
with Tris–Cl, pH 8.0. A 2.5-ll volume of buccal cells typi-
cally sufﬁced for PCR ampliﬁcation. TNFB gene was ampli-
ﬁed using polymerase chain reaction (PCR). Sequences of
the primers 50-CCGTGCTTCGTGCTTTGGACTA-30 and
50-AGAGCTGGTGGGGACATGTCG-30 were self-synthe-
sized using the DNA synthesizer (ABI, 392 USA) to identify
the polymorphism +252A>G in intron 1 (Messer et al.,
1991). Two hundred nanograms of genomic DNA extracted
from venous blood was added to a 15-ll reaction mixture
containing 0.5 lM of each primer with 200 lM of each
dNTP, 67 mM Tris–HCl, 16 mM (NH4)2SO4, 0.01%
Tween-20, 1 mM MgCl2 and 0.45 U Taq DNA polymerase.
Ampliﬁcation conditions were 95 C for 5 min followed by
30 cycles of 95 C for 30 s, 58 C for 30 s, 72 C for 45 s.
A ﬁnal extension of 72 C for 5 min was included. Following
ampliﬁcation, 5-ll of PCR amplicon was incubated over-
night with 5 U of NcoI (New England Biolabs) at 37 C.
The digested PCR fragments were separated on 3% NuSieve
gel (BMA, Bioproducts, USA), and visualized by ethidium
bromide staining. The LTA*NcoI allele G was identiﬁed
by 545- and 196-bp fragments and allele A by a single
741-bp fragment.
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Figure 1 Association between the severity of asthma of 60
asthmatic Saudi children and the genotypes of LTA*NcoI.
Table 1 Sharing of lymphotoxina gene polymorphism with asthmatic Saudi children.
Parameter No LTaNcoI genotypes v2 p
GG GA AA
Asthmatic 60 18 (30%) 18 (30%) 24 (40%) 1.12 0.57
Non-asthmatics 56 12 (21%) 20 (36%) 24 (43%)
Severity of asthma
Mild intermittent 12 6/12 (50%) 2/12 (17%) 2/12 (33%)
Mild persistent 20 6/20 (30%) 6/20 (30%) 8/20 (40%)
Moderate persistent 18 6/18 (33%) 8/18 (44%) 4/18 (22%)
Severe persistent 10 0 2/10 (20%) 8/10 (80%)
Association between b+252 tumour necrosis factor polymorphism and asthma in western Saudi children 1092.3. Data analysis
Associations between genotypes and asthma were tested by the
Mantel–Haenszel v2 test for linear association (SPSS 10.1 for
VAX/VMS, SPSS Inc., USA).
3. Results
Asthma was deﬁned as a positive answer to the questions ‘Has
your child had an attack of asthma on more than one occa-
sion?’ Other questions included ‘Has your child ever had at-
tacks of shortness of breath with wheezing?’ and ‘Has your
doctor ever told you that your child has asthma?’ Our sample
contained 60 children with asthma plus 56 non-asthmatics.
The patients included 28 males and 32 females with mean
age ± standard deviation (SD) of 8.3 ± 3.6 years (range 1–
15 year). Ninety-ﬁve percent of the asthmatics suffered eleva-
tions of the total serum IgE above 72% of the age and sex
matched population (unpublished data).
In this study, we considered the deﬁnition of family history
of bronchial asthma or allergy as any ﬁrst-degree relative with
a diagnosis of asthma or allergy (Salam et al., 2004). However,
we reported that the frequency of the family history was more
common among our Saudi asthmatic cases (36/60; 60%) than
isolated asthmatic ones.
All subjects were typed for LTA gene polymorphism,
LTA*NcoI, located in the ﬁrst intron of the LTA gene. The
allele frequencies of LTA*NcoI-G and A (number of alleles
counted = 120) were 0.45 and 0.55, respectively. However, it
is of interest that the polymorphism in the LTA*NcoI showed
the most predominant A-allele in either the asthmatic (55%) or
the non-asthmatic (61%) children in Saudis. In our Saudi asth-
matic sample, it was evident that the frequency of the genotype
LTA*NcoI-A/A (0.40; n= 60) was the preferable genotype to
the other genotypes G/A (0.30), and G/G (0.30). In the non-
asthmatic control sample (n= 56), the frequencies of the A/
A, G/A, and G/G were 0.43, 0.36, and 0.21, respectively (Table
1).
In our study, the severe persistent bronchial asthma was
associated with the LTA*NcoI-AA genotype at a frequency
of 80% (Fig. 1). In contrast, the genotype LTA*NcoI-GG
are associated with the mildest form of ‘mild intermittent asth-
ma’ where the genotype GG represents the maximum fre-
quency (50%) and severe persistent BA (0%). However,
someone might predict the severity of asthma and conse-
quently the phenotype of an asthmatic individual knowing
the polymorphism of the LTA*NcoI. The moderate persistent
BA phenotypes are strongly linked to the LTA*NcoI-GA
genotype.4. Discussion
Our study includes a simple deﬁnition of asthma, based on a
standard questionnaire. Answers to the question ‘Have you
had an attack of asthma on more than one occasion?’ will de-
pend greatly on the previous medical care and education of
individual subjects. In order to fully understand the effects
of TNF polymorphisms on the asthma phenotype, it may
nonetheless be desirable in future studies to investigate the
relationship between genotypes and other indices such as med-
ication use, bronchial responsiveness testing, or bronchial
biopsy. In the studies reported so far, there are still controver-
sies over the effects of TNF polymorphisms on asthma. Few
studies of linkage between asthma in non-Caucasian popula-
tions have been reported. In addition, linkage studies of asth-
ma in childhood have not been reported.
The results are in keeping with functional studies implicat-
ing TNF in asthma (Broide et al., 1992; Virchow et al., 1995;
Shah et al., 1995), and suggest that genetic inﬂuences on
inﬂammation are part of the pathogenesis of the disease. The
results also imply that treatment strategies directed against
TNF may be effective in the management of asthma. A study
reported that the family history of asthma was more common
among cases than among controls (41.9% vs. 20.6%;
p= 0.0002) (Salam et al., 2004). Moreover, out of our scope,
there was no statistical difference in maternal education level,
yearly family income, or access to health care measured in
terms of health insurance coverage between cases and controls.
In this study, the frequency of family history of 60% rational-
ized the contribution of environmental parameters besides the
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addition, it was observed from the localization of our asth-
matic families that more than 93% asthmatic cases lived in
the randomized areas of KSA (Al-Moamary et al., 2009) that
were characterized by the air pollution due to wood or oil
smoke, soot, or exhaust, rather than the lack of green areas
(Personal data). Asthma diagnosis before 5 years of age was
associated with exposures in the ﬁrst year of life to wood or
oil smoke, soot, or exhaust, cockroaches, herbicides,
pesticides, and farm crops, farm dust, or farm animals (Dun-
stan et al., 2005; Kim et al., 2006). The odd ratios (ORs) for
herbicide, pesticide, farm animal, and crops were largest
among children with early-onset persistent asthma.
The results obtained on atopic asthmatic subjects by the
analysis of polymorphisms for the two TNF loci show a signif-
icant allele sharing for the LTA*NcoI polymorphism and
atopy, but not for the BHR phenotype or for clinical asthma.
The LTA*NcoI-G allele is associated with a lower LTA re-
sponse (Messer et al., 1991) and a higher LTA*NcoI-A. It is
possible that the LTA gene intron 1, which contains the NcoI
polymorphism, includes a regulatory element that may affect
TNFA gene expression (Albuquerque et al., 1998). Failure to
ﬁnd an association in some studies was not due to the sample
size (Castro et al., 2000; Noguchi et al., 2002; Shin et al., 2004),
although a minor contribution of the LTA NcoI polymor-
phism to asthma susceptibility cannot be excluded.
In conclusion, although environmental factors clearly inﬂu-
ence the onset, progression and severity of this disease, family
and twin studies indicate that genetic variation also inﬂuences
susceptibility. We report that it is unlikely that the LTA*NcoI
polymorphisms or any other one, for example, TNF 1031C/
T, 308G/A, 238G/A polymorphisms inﬂuence asthma sus-
ceptibility individually, but that the haplotype of variants may
be functional or may be in linkage disequilibrium with other
functional single-nucleotide polymorphisms. Moreover, a large
scale case-control study might be needed to clarify the func-
tional effect of the polymorphism of the genetic variants of
TNF gene in the pathogenesis of asthma.Acknowledgments
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